| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |